I was recruited to Cedars-Sinai to direct the Inflammatory Bowel Diseases Drug Discovery and Development (IBD3) unit for the Inflammatory Bowel and Immunobiology Research Institute. IBD3 is a unique concept by design, in which an industry-caliber target discovery and development unit is integrated with an academic research program to accelerate the pace at which scientific findings are brought to bear on patient care."
The Bilsborough Laboratory's Inflammatory Bowel Diseases Drug Discovery and Development unit is composed of research scientists and clinicians with experience in both the biopharmaceutical industry and clinical research.
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Bilsborough Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Nat Immunol. 2015 Feb;16(2):137-139
Bilsborough J, Mudri S, Chadwick E, Harder B, Dillon SR.
J Immunol. 2010 Nov 15;185(10):6023-6030.
Bilsborough J, Viney JL.
Expert Opin Drug Discov. 2006 Jun;1(1):69-83.